<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66808</article-id><article-id pub-id-type="doi">10.7554/eLife.66808</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Expansion of CD10<sup>neg</sup> neutrophils and HLA-DR<sup>neg/low</sup> monocytes driving inflammatory responses after myocardial infarction</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-223358"><name><surname>Fraccarollo</surname><given-names>Daniela</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7756-6032</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224262"><name><surname>Neuser</surname><given-names>Jonas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224263"><name><surname>Möller</surname><given-names>Julian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1818-6782</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58871"><name><surname>Riehle</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224264"><name><surname>Galuppo</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224265"><name><surname>Bauersachs</surname><given-names>Johann</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cardiology and Angiology</institution>, <institution>Medical School Hannover</institution>, <addr-line><named-content content-type="city">Hannover</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Roy J. and Lucille A. Carver College of Medicine</institution>, <institution>Medical School Hannover</institution>, <addr-line><named-content content-type="city">Hannover</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-184943"><name><surname>Emoto</surname><given-names>Noriaki</given-names></name><role>Reviewing editor</role><aff><institution>Kobe Pharmaceutical University</institution>, <country>Japan</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>fraccarollo.daniela@mh-hannover.de</email> (DF);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>07</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66808</elocation-id><history><date date-type="received"><day>22</day><month>01</month><year>2021</year></date><date date-type="accepted"><day>11</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Fraccarollo et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Fraccarollo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66808-v1.pdf"/><abstract><p><bold>Background:</bold> Immature neutrophils and HLA-DR<sup>neg/low</sup> monocytes expand in cancer, autoimmune diseases and viral infections, but their appearance and immunoregulatory effects on T-cells after acute myocardial infarction (AMI) remain underexplored.</p><p><bold>Methods and Results:</bold> We found an expansion of circulating immature CD16<sup>+</sup>CD66b<sup>+</sup>CD10<sup>neg</sup> neutrophils and CD14<sup>+</sup>HLA-DR<sup>neg/low </sup>monocytes in AMI patients, correlating with cardiac damage, function and levels of immune-inflammation markers. Immature CD10<sup>neg</sup> neutrophils expressed high amounts of MMP-9 and S100A9, and displayed resistance to apoptosis. Moreover, we found that increased frequency of CD10<sup>neg</sup> neutrophils and elevated circulating IFN-γ levels were linked, mainly in patients with expanded CD4<sup>+</sup>CD28<sup>null </sup>T-cells. Notably, the expansion of circulating CD4<sup>+</sup>CD28<sup>null</sup> T-cells was associated with cytomegalovirus (CMV) seropositivity. Using bioinformatic tools we identified a tight relationship among the peripheral expansion of immature CD10<sup>neg</sup> neutrophils, CMV IgG titers, and circulating levels of IFN-γ and IL-12 in patients with AMI. At a mechanistic level, CD10<sup>neg</sup> neutrophils enhanced IFN-γ production by CD4<sup>+</sup> T-cells through a contact-independent mechanism involving IL-12. <italic>I</italic><italic>n vitro</italic> experiments also highlighted that HLA-DR<sup>neg/low </sup>monocytes do not suppress T-cell proliferation but secrete high levels of pro-inflammatory cytokines after differentiation to macrophages and IFN-γ stimulation. Lastly, using a mouse model of AMI, we showed that immature neutrophils (CD11b<sup>pos</sup>Ly6G<sup>pos</sup>CD101<sup>neg</sup> cells) are recruited to the injured myocardium and migrate to mediastinal lymph nodes shortly after reperfusion.</p><p><bold>Conclusions:</bold> Immunoregulatory functions of CD10<sup>neg</sup> neutrophils play a dynamic role in mechanisms linking myeloid cell compartment dysregulation, Th1-type immune responses and inflammation after AMI.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>BA 1742/8-1</award-id><principal-award-recipient><name><surname>Fraccarollo</surname><given-names>Daniela</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>BA 1742/8-1</award-id><principal-award-recipient><name><surname>Bauersachs</surname><given-names>Johann</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (Publication No. 85-23, revised 1985). All procedures were approved by the Regierung von Unterfranken (Würzburg, Germany; permit No. 54-2531.01-15/07) and by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (Oldenburg, Germany; permit No. 33.12-42502-04-11/0644; 33.9-42502-04-13/1124 and 33.12-42502-04-17/2702).</p></fn><fn fn-type="other"><p>Human subjects: The study protocol is in accordance with the ethical guidelines of the 1975 declaration of Helsinki and has been approved by the local ethics committee of Hannover Medical School. Patients referred to our department for acute coronary syndrome (ACS) were included after providing written informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 1-figure supplement 1 and Figure 3-figure supplement 1.</p></sec><supplementary-material><ext-link xlink:href="elife-66808-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>